Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 3/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8558665 | 0.82 | MEN1 (0.61) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL27311969 | 0.82 | CA12 (0.37) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL17776266 | 0.82 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL26700020 | 0.81 | FAAH (0.47) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL16592000 | 0.81 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL27103869 | 0.81 | CA12 (0.39) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL9921404 | 0.80 | CASP2 (0.48) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL24760591 | 0.79 | CASP2 (0.53) | MEN1KMT2ACASP2NAAAFAAH | |
| SCHEMBL1171551 | 0.78 | CASP2 (0.47) | ALDH1A1MEN1KMT2ACASP2NAAA | |
| SCHEMBL13096794 | 0.78 | KDM4E (0.50) | ALDH1A1MEN1KMT2ATDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021252761-A2 | MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-12-16 | — | — | WO | disclosed |